Ginkgo Bioworks Holdings (DNA) Capital Leases (2020 - 2022)

Ginkgo Bioworks Holdings has reported Capital Leases for 3 years, with the latest figure at $59.8 million in Q3 2022.

• For the quarter ending Q3 2022, Capital Leases rose 267.85% year-over-year to $59.8 million; the trailing twelve-month figure through Sep 2022 stood at $59.8 million (up 267.85% YoY), and the FY2021 full-year result was $22.3 million, up 34.9% from the prior year.
• Capital Leases for Q3 2022 stood at $59.8 million, up from $51.5 million in the prior quarter.
• The five-year high for Capital Leases was $59.8 million in Q3 2022, with the low at $16.3 million in Q3 2021.
• Historically, Capital Leases has averaged $32.3 million across 3 years, with a median of $24.8 million in 2021.
• Annual changes were most pronounced in 2021 — Capital Leases soared 34.9% — and 2022, when it jumped 267.85%.
• Ginkgo Bioworks Holdings' Capital Leases stood at $16.5 million in 2020, then surged by 34.9% to $22.3 million in 2021, then surged by 168.55% to $59.8 million in 2022.
• The last three Capital Leases figures came in at $59.8 million (Q3 2022), $51.5 million (Q2 2022), and $27.3 million (Q1 2022), per Business Quant data.